Researchers from Rice University and Baylor College of Medicine have developed a new treatment that eliminates advanced-stage ...

such as CCNE1 overexpression in ovarian cancer. The impact of WEE1 inhibition could potentially be amplified further by simultaneously targeting a similar cell cycle-regulating kinase known as ...

A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs ...

Fibroblast growth factor receptors (FGFRs) are critical drivers of oncogenesis in various solid tumors, including urothelial carcinoma, hepatocellular carcinoma, ovarian cancer and lung adenocarcinoma ...

Maintaining treatment with CDK4/6 inhibitors significantly suppresses the growth of breast cancer cells, even after drug resistance has developed, according to new research.

This study presents fundamental insights into overcoming resistance in hormone receptor-positive breast cancer by demonstrating that sustained CDK4/6 inhibitor treatment, either alone or in ...

The addition of sintilimab to neoadjuvant chemoradiotherapy achieved a 60% pathological complete response rate vs 47.3% with ...

Investigators conducted a retrospective review that spanned 10 years with the goals of describing the clinical ...